Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance

被引:75
作者
Larsson, H [1 ]
Ahrén, B [1 ]
机构
[1] Univ Lund, Dept Med, Malmo, Sweden
关键词
D O I
10.2337/diacare.23.5.650
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To characterize in detail the association between insulin sensitivity and islet function in relation to glucose tolerance in nondiabetic subjects. RESEARCH DESIGN AND METHODS - The study included 108 postmenopausal women, aged 57-59 years, with normal glucose tolerance (NGT) or impaired glucose tolerance (IGT) and measured glucose tolerance (World Health Organization, 75 g glucose), insulin sensitivity (euglycemic-hyperinsulinemic clamp), and islet function (the 2-5 min insulin responses [AIR] and glucagon [AGR] responses to 5 g intravenous arginine at fasting, 14 and >25 mmol/l glucose levels). The product of insulin sensitivity and secretion was calculated (disposition index [DI]) and used to study the relationship between the two parameters. RESULTS - Insulin sensitivity and insulin secretion were highly inversely correlated in a hyperbolic manner (r > 0.64, P < 0.001) in women with NGT (n = 71). Women with IGT (n = 37) had reduced insulin sensitivity compared with women with NGT (P = 0.011). The AIRs were not appropriately increased in relation to the reduced insulin sensitivity in the IGT women, demonstrated as reduced DI in IGT compared with NGT (P < 0.001). Further, women with IGT had an increased AGR (P < 0.001) and a reduced glucose inhibition of glucagon secretion (slope P = 0.014) compared with women with NGT In a multivariate regression model including all of the 108 women, 2-h glucose was independently determined by the DI, the AGR, and the slope(AGR) (r = 0.63, P < 0.001). CONCLUSIONS - We have shown that both the individual ability to adapt insulin secretion to the ambient insulin sensitivity and the level of glucagon secretion are important parameters for maintenance of NGT Therefore, islet dysfunction in IGT involves low insulin and high glucagon secretion, which present potential targets for correcting impaired glycemia.
引用
收藏
页码:650 / 657
页数:8
相关论文
共 32 条
[21]   FASTING BLOOD-GLUCOSE IN DETERMINING THE PREVALENCE OF DIABETES IN A LARGE, HOMOGENEOUS POPULATION OF CAUCASIAN MIDDLE-AGED WOMEN [J].
LARSSON, H ;
AHREN, B ;
LINDGARDE, F ;
BERGLUND, G .
JOURNAL OF INTERNAL MEDICINE, 1995, 237 (06) :537-541
[22]   Islet dysfunction in obese women with impaired glucose tolerance [J].
Larsson, H ;
Ahren, B .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (04) :502-509
[23]   INSULIN-RESISTANCE AND INSULIN SECRETORY DYSFUNCTION AS PRECURSORS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS - PROSPECTIVE STUDIES OF PIMA-INDIANS [J].
LILLIOJA, S ;
MOTT, DM ;
SPRAUL, M ;
FERRARO, R ;
FOLEY, JE ;
RAVUSSIN, E ;
KNOWLER, WC ;
BENNETT, PH ;
BOGARDUS, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (27) :1988-1992
[24]   INSULIN WITHIN ISLETS IS A PHYSIOLOGIC GLUCAGON-RELEASE INHIBITOR [J].
MARUYAMA, H ;
HISATOMI, A ;
ORCI, L ;
GRODSKY, GM ;
UNGER, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (06) :2296-2299
[25]   ROLE OF REDUCED SUPPRESSION OF GLUCOSE-PRODUCTION AND DIMINISHED EARLY INSULIN RELEASE IN IMPAIRED GLUCOSE-TOLERANCE [J].
MITRAKOU, A ;
KELLEY, D ;
MOKAN, M ;
VENEMAN, T ;
PANGBURN, T ;
REILLY, J ;
GERICH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (01) :22-29
[26]   BETA-CELLS IN TYPE-II DIABETES-MELLITUS [J].
PORTE, D .
DIABETES, 1991, 40 (02) :166-180
[27]   DEFECTS IN INSULIN-SECRETION AND ACTION IN WOMEN WITH A HISTORY OF GESTATIONAL DIABETES [J].
RYAN, EA ;
IMES, S ;
LIU, DT ;
MCMANUS, R ;
FINEGOOD, DT ;
POLONSKY, KS ;
STURIS, J .
DIABETES, 1995, 44 (05) :506-512
[28]   THE NATURAL-HISTORY OF IMPAIRED GLUCOSE-TOLERANCE IN THE PIMA-INDIANS [J].
SAAD, MF ;
KNOWLER, WC ;
PETTITT, DJ ;
NELSON, RG ;
MOTT, DM ;
BENNETT, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (23) :1500-1506
[29]   Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His(1),des-Phe(6),Glu(9)]glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists [J].
VanTine, BA ;
Azizeh, BY ;
Trivedi, D ;
Phelps, JR ;
Houslay, MD ;
Johnson, DG ;
Hruby, VJ .
ENDOCRINOLOGY, 1996, 137 (08) :3316-3322
[30]  
WARD WK, 1985, J CLIN ENDOCR METAB, V61, P1039, DOI 10.1210/jcem-61-6-1039